Indefinite Delivery Contract 36E79722D0033
Award Date 1/14/23
Last Date to Order 1/13/26
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...
- The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the...
- Sandoz Inc. was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule to supply a comprehensive range of pharmaceutical products to the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 12. The contract, valued at $683.2 million with an ultimate completion date of August 14, 2028, was awarded on an unrestricted basis without set-asides on August 15, 2023. Sandoz Inc. will provide various...
- The federal government, through the National Acquisition Center (NAC) of the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications. The $7,402,374.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of January 14, 2026. The contract aims to procure Amoxicillin/Clavulanate Tablets to meet the...
- The federal contract IDV award is a single award Indefinite Delivery Contract between the Department of Veterans Affairs (VA) National Acquisition Center and Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications through the VA and Department of Defense (DoD) pharmaceutical prime vendor programs. The contract has a base period of performance from May 30, 2021 to May 29, 2022 with four one-year option periods, and a ceiling value of $9,803,319.55. The...
- The federal contract IDV award is for the supply of Thioridazine HCl tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) through the VA's Pharmaceutical Prime Vendor program. The single-award indefinite delivery contract was issued by the VA National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, with a ceiling value of $267,666.40 and a period of...
- The National Acquisition Center, a civilian agency within the Department of Veterans Affairs, has awarded an Indefinite Delivery Contract to Sandoz Inc., a global pharmaceutical company, to supply Latanoprost Ophthalmic Solution for the VA, DoD, Bureau of Prisons, and Indian Health Service. This single-award contract has a ceiling value of $23,010,467.85 and a period of performance from March 21, 2022, to March 20, 2023, with four 1-year option periods. The contract aims to provide an...
- The federal contract IDV award is for the supply of Amoxicillin/Clavulanate Potassium (K) Suspension products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Services (IHS). The contract was awarded to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, and a division of Novartis. The contract has a base year from January 15, 2023, to January 14, 2024, with four one-year option periods, for a total potential...
- The Department of Veterans Affairs National Acquisition Center has awarded Organon LLC a single-award Indefinite Delivery Contract (IDC) worth up to $119,538,562.32 to provide Infliximab Injection 100 mg/vial, a biosimilar medication, to the VA, Bureau of Prisons, and Indian Health Service. The contract has a 1-year base period starting September 1, 2023 with four 1-year option periods, for a total potential period of performance through August 31, 2026. This IDC supports the VA's Pharmaceutical...
- The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sandoz Inc. for the delivery of amitriptyline hydrochloride tablets. The single award contract has a potential value of $14.1 million over a one year base period and four one year option periods extending to March 6, 2023. The originating pre-solicitation notice sought offers for an unrestricted procurement to supply amitriptyline hydrochloride tablets to meet the estimated annual...